MicroPort EP released its 2026 interim report, showing attributable net profit of 40.09 million yuan in the first half, up 22.7% year on year. Operating revenue was 275 million yuan, up 23.02% year on year. Attributable net profit excluding non-recurring items was 3.16 million yuan, down 84.8% year on year. Net operating cash flow was 1.24 million yuan, down 98.1% year on year. In the second quarter, operating revenue was 149 million yuan, up 24.8% year on year, while attributable net profit was 11 million yuan, down 25.7% year on year. As of the end of the second quarter, total assets stood at 2.036 billion yuan, up 2.2% from the end of the previous year, and attributable net assets were 1.814 billion yuan, up 0.7% from the end of the previous year. The company said its electrophysiology interventional diagnosis and ablation treatment business continued to grow, with cumulative three-dimensional cardiac electrophysiology procedures exceeding 100,000 cases, covering more than 1,100 hospitals, and procedure volume for core products rising more than 45% compared with the same period last year.
Shanghai MicroPort EV MedTech Co. Ltd. AMicroPort EP's H1 attributable net profit rose 22.7% YoY to 40.09 million yuan on 23.02% revenue growth.
